112 related articles for article (PubMed ID: 9871623)
1. Selective inhibition of low affinity IgE receptor (CD23) processing.
Bailey S; Bolognese B; Buckle DR; Faller A; Jackson S; Louis-Flamberg P; McCord M; Mayer RJ; Marshall LA; Smith DG
Bioorg Med Chem Lett; 1998 Jan; 8(1):29-34. PubMed ID: 9871623
[TBL] [Abstract][Full Text] [Related]
2. Hydroxamate-based inhibitors of low affinity IgE receptor (CD23) processing.
Bailey S; Bolognese B; Buckle DR; Faller A; Jackson S; Louis-Flamberg P; McCord M; Mayer RJ; Marshall LA; Smith DG
Bioorg Med Chem Lett; 1998 Jan; 8(1):23-8. PubMed ID: 9871622
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of low affinity IgE receptor (CD23) processing: P1' bicyclomethyl substituents.
Bailey S; Bolognese B; Faller A; Louis-Flamberg P; MacPherson DT; Mayer RJ; Marshall LA; Milner PH; Mistry J; Smith DG; Ward JG
Bioorg Med Chem Lett; 1999 Nov; 9(21):3165-70. PubMed ID: 10560745
[TBL] [Abstract][Full Text] [Related]
4. The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.
Steinman DH; Curtin ML; Garland RB; Davidsen SK; Heyman HR; Holms JH; Albert DH; Magoc TJ; Nagy IB; Marcotte PA; Li J; Morgan DW; Hutchins C; Summers JB
Bioorg Med Chem Lett; 1998 Aug; 8(16):2087-92. PubMed ID: 9873491
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.
Yamamoto M; Tsujishita H; Hori N; Ohishi Y; Inoue S; Ikeda S; Okada Y
J Med Chem; 1998 Apr; 41(8):1209-17. PubMed ID: 9548812
[TBL] [Abstract][Full Text] [Related]
6. IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (Fc epsilonRII).
Christie G; Barton A; Bolognese B; Buckle DR; Cook RM; Hansbury MJ; Harper GP; Marshall LA; McCord ME; Moulder K; Murdock PR; Seal SM; Spackman VM; Weston BJ; Mayer RJ
Eur J Immunol; 1997 Dec; 27(12):3228-35. PubMed ID: 9464810
[TBL] [Abstract][Full Text] [Related]
7. The amyloid precursor protein (APP) and the angiotensin converting enzyme (ACE) secretase are inhibited by hydroxamic acid-based inhibitors.
Parvathy S; Hussain I; Karran EH; Turner AJ; Hooper NM
Biochem Soc Trans; 1998 Aug; 26(3):S242. PubMed ID: 9765961
[No Abstract] [Full Text] [Related]
8. MMP-13 selective alpha-sulfone hydroxamates: identification of selective P1' amides.
Fobian YM; Freskos JN; Barta TE; Bedell LJ; Heintz R; Kassab DJ; Kiefer JR; Mischke BV; Molyneaux JM; Mullins P; Munie GE; Becker DP
Bioorg Med Chem Lett; 2011 May; 21(10):2823-5. PubMed ID: 21493063
[TBL] [Abstract][Full Text] [Related]
9. Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.
Xue CB; He X; Corbett RL; Roderick J; Wasserman ZR; Liu RQ; Jaffee BD; Covington MB; Qian M; Trzaskos JM; Newton RC; Magolda RL; Wexler RR; Decicco CP
J Med Chem; 2001 Oct; 44(21):3351-4. PubMed ID: 11585440
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme secretase is inhibited by zinc metalloprotease inhibitors and requires its substrate to be inserted in a lipid bilayer.
Parvathy S; Oppong SY; Karran EH; Buckle DR; Turner AJ; Hooper NM
Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):37-43. PubMed ID: 9355732
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.
Jacobson IC; Reddy PG; Wasserman ZR; Hardman KD; Covington MB; Arner EC; Copeland RA; Decicco CP; Magolda RL
Bioorg Med Chem Lett; 1998 Apr; 8(7):837-42. PubMed ID: 9871551
[TBL] [Abstract][Full Text] [Related]
12. Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships.
Duan JJ; Chen L; Wasserman ZR; Lu Z; Liu RQ; Covington MB; Qian M; Hardman KD; Magolda RL; Newton RC; Christ DD; Wexler RR; Decicco CP
J Med Chem; 2002 Nov; 45(23):4954-7. PubMed ID: 12408705
[TBL] [Abstract][Full Text] [Related]
13. MMPs inhibitors: new succinylhydroxamates with selective inhibition of MMP-2 over MMP-3.
Marcq V; Mirand C; Decarme M; Emonard H; Hornebeck W
Bioorg Med Chem Lett; 2003 Sep; 13(17):2843-6. PubMed ID: 14611841
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship of hydroxamate-based inhibitors on the secretases that cleave the amyloid precursor protein, angiotensin converting enzyme, CD23, and pro-tumor necrosis factor-alpha.
Parkin ET; Trew A; Christie G; Faller A; Mayer R; Turner AJ; Hooper NM
Biochemistry; 2002 Apr; 41(15):4972-81. PubMed ID: 11939793
[TBL] [Abstract][Full Text] [Related]
15. Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.
Curtin ML; Garland RB; Davidsen SK; Marcotte PA; Albert DH; Magoc TJ; Hutchins C
Bioorg Med Chem Lett; 1998 Jun; 8(12):1443-8. PubMed ID: 9873367
[TBL] [Abstract][Full Text] [Related]
16. CD23 shedding: requirements for substrate recognition and inhibition by dipeptide hydroxamic acids.
Mayer RJ; Flamberg PL; Katchur SR; Bolognese BJ; Smith DG; Marolewski AE; Marshall LA; Faller A
Inflamm Res; 2002 Feb; 51(2):85-90. PubMed ID: 11926319
[TBL] [Abstract][Full Text] [Related]
17. New drugs on the horizon: matrix metalloproteinase inhibitors.
Rothenberg ML; Nelson AR; Hande KR
Stem Cells; 1999; 17(4):237-40. PubMed ID: 10437989
[No Abstract] [Full Text] [Related]
18. Protease inhibitors: Synthesis of L-alanine hydroxamate sulfonylated derivatives as inhibitors of clostridium histolyticum collagenase.
Supuran CT; Briganti F; Mincione G; Scozzafava A
J Enzyme Inhib; 2000; 15(2):111-28. PubMed ID: 10938538
[TBL] [Abstract][Full Text] [Related]
19. Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.
Tommasi RA; Weiler S; McQuire LW; Rogel O; Chambers M; Clark K; Doughty J; Fang J; Ganu V; Grob J; Goldberg R; Goldstein R; Lavoie S; Kulathila R; Macchia W; Melton R; Springer C; Walker M; Zhang J; Zhu L; Shultz M
Bioorg Med Chem Lett; 2011 Nov; 21(21):6440-5. PubMed ID: 21937229
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.
Zhang C; Lovering F; Behnke M; Zask A; Sandanayaka V; Sun L; Zhu Y; Xu W; Zhang Y; Levin JI
Bioorg Med Chem Lett; 2009 Jul; 19(13):3445-8. PubMed ID: 19464885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
